Connect Biopharma Limite...
(CNTB)
undefined
undefined%
At close: undefined
1.12
0.76%
After-hours Dec 13, 2024, 03:59 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | - | - | - | - |
Cost of Revenue | 988.00K | 1.03M | - | - | - |
Gross Profit | -988.00K | -1.03M | - | - | - |
Operating Income | -62.07M | -117.66M | -99.15M | -30.30M | -15.99M |
Interest Income | 5.20K | 1.56M | 97.67K | 109.84K | 154.65K |
Pretax Income | -59.38M | -116.12M | -204.94M | -119.37M | -24.46M |
Net Income | -59.50M | -116.42M | -205.21M | -120.30M | -24.02M |
Selling & General & Admin | 13.53M | 20.37M | 19.23M | 7.31M | 1.41M |
Research & Development | 51.91M | 95.26M | 81.34M | 23.12M | 15.44M |
Other Expenses | -4.35M | -940.31K | -2.98M | -1.07M | -411.44K |
Operating Expenses | 62.07M | 114.69M | 97.59M | 29.36M | 16.44M |
Interest Expense | - | 21.03K | 6.91K | 6.43K | 7.69K |
Selling & Marketing Expenses | 13.51M | - | - | - | - |
Cost & Expenses | 62.07M | 114.69M | 97.59M | 29.36M | 16.44M |
Income Tax | 120.00K | 297.52K | 266.47K | 934.46K | -442.49K |
Shares Outstanding (Basic) | 55.07M | 55.04M | 52.27M | 53.94M | 55.82M |
Shares Outstanding (Diluted) | 55.07M | 55.04M | 52.27M | 53.94M | 55.82M |
EPS (Basic) | -1.08 | -14.5 | -25 | -14.45 | -3.02 |
EPS (Diluted) | -1.08 | -14.5 | -25 | -14.45 | -3.02 |
EBITDA | -58.37M | -111.31M | -204.93M | -118.21M | -24.78M |
Depreciation & Amortization | 988.00K | 1.01M | 640.98K | 221.05K | 114.61K |